‘Value’ is the common thread in PwC’s annual report on top health industry trends.
As the Internet of Things and the reimbursement environment transform the healthcare ecosystem, device manufacturers must position themselves to adapt.
Device companies will need to assess their business model in order to compete in an outcomes-based reimbursement environment.
Correct usage of codes impacts product positioning, pricing, launch and customer support.
Should your IDE device be reimbursed? FDA’s latest draft guidance will help CMS make the decision.
Consider taking a multi-pronged approach to this complex landscape.
How do marketing messages affect third-party payers?
That depends on where you sit.
What can we learn about how new technologies become eligible for additional payment?
After preparing for three key issues, follow these recommended strategies when pursuing the market in Japan.